US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Mesabi

30.70

-0.0800-0.26%

Volume:1.08K

Turnover:33.05K

Market Cap:402.78M

PE:23.40

High:30.70

Open:30.70

Low:30.70

Close:30.78

52wk High:42.38

52wk Low:22.55

Shares:13.12M

Float Shares:13.11M

Volume Ratio:1.24

T/O Rate:0.01%

Dividend:1.28

Dividend Rate:4.17%

EPS(TTM):1.31

EPS(LYR):7.11

ROE:29.57%

ROA:17.07%

PB:19.10

PE(LYR):4.32

Loading ...

Overview Company News Filings

Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment

Mesoblast (ASX:MSB) Is Down 6.4% After Encouraging FDA Feedback On Back Pain Cell Therapy Data – Has The Bull Case Changed?

Simply Wall St.

Mesoblast (ASX:MSB) Valuation Check After FDA Backs Rexlemestrocel L’s Pain And Opioid Reduction Data

Simply Wall St.

Mesabi Trust Down Over 11%, on Pace for Largest Percent Decrease Since February 2025 -- Data Talk

Press Release: Mesabi Trust Press Release

Does Mesoblast’s New Board Leadership After First FDA Approval Change The Bull Case For ASX:MSB?

Simply Wall St.

New Crypto Exchange BitGW Offers Secure and Compliant Trading: Review

Mesoblast (ASX:MSB) Valuation Check As Leadership Changes And Debt Refinancing Reset Expectations

Simply Wall St.

Malaysian Shares End in Red Bucking Regional Gains; MSB Global's Shares Rally 18%

MT Newswires Live

MSB Global Unit, Thai Sin Anant Form Auto Parts JV in Thailand; Shares Rally 18%

MT Newswires Live

Press Release: Mesoblast Announces Changes to Board of Directors' Leadership Roles

Press Release: Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line

Aspire Announces Major Australia, EU and US Regulatory Milestones, Marking a New Chapter in Its Global Expansion

Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD

Is Mesoblast (ASX:MSB) Using High-Profile Conferences To Recast Its Core Investment Narrative?

Simply Wall St.

Mesoblast (ASX:MSB) Valuation Check as Investors Eye Piper Sandler Healthcare Conference Update

Simply Wall St.

Matrixport Appoints Dominik Oggenfuss as Chief Executive Officer of Matrixport Asset Management AG

Mesoblast Participation at Piper Sandler Conference

Mesoblast (ASX:MSB) Is Up 17.3% After Lifting Revenue Guidance and Announcing NIH Trial Collaboration Has The Bull Case Changed?

Simply Wall St.

A Look at Mesoblast (ASX:MSB) Valuation as New Ryoncil Sales Forecast and Pivotal Trial Spark Attention

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MSB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSB\",,,,,undefined,":{"symbol":"MSB","market":"US","secType":"STK","nameCN":"Mesabi","latestPrice":30.7,"timestamp":1774618680886,"preClose":30.78,"halted":0,"volume":1079,"delay":0,"changeRate":-0.002599090318388624,"floatShares":13109915,"shares":13120010,"eps":1.311705,"marketStatus":"Trading","change":-0.08,"latestTime":"03-27 09:38:46 EDT","open":30.7,"high":30.7,"low":30.7,"amount":33050.915898,"amplitude":0,"askPrice":32.01,"askSize":51,"bidPrice":30,"bidSize":38,"shortable":3,"etf":0,"ttmEps":1.311705,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774641600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":30.78,"dividendRate":0.041694,"postHourTrading":{"tag":"盘后","latestPrice":30.75,"preClose":30.78,"latestTime":"16:23 EDT","volume":278,"amount":8550.86,"timestamp":1774556597194,"change":-0.03,"changeRate":-0.000975,"amplitude":0.000975},"volumeRatio":1.243548,"impliedVol":0.6758,"impliedVolPercentile":0.9163},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSB\",,,,,undefined,":{"symbol":"MSB","floatShares":13109915,"roa":"17.07%","roe":"29.57%","lyrEps":7.109311,"volumeRatio":1.243548,"shares":13120010,"dividePrice":1.28,"high":30.7,"amplitude":0,"preClose":30.78,"low":30.7,"week52Low":22.55,"pbRate":"19.10","psRate":"19.38","week52High":42.38,"institutionHeld":0.4882,"latestPrice":30.7,"committee":-0.146067,"eps":1.311705,"divideRate":0.041694,"volume":1079,"delay":0,"ttmEps":1.311705,"open":30.7,"prevYearClose":38.52,"prevWeekClose":29.32,"prevMonthClose":30.37,"prevQuarterClose":38.52,"fiveDayClose":29.32,"twentyDayClose":30.37,"sixtyDayClose":38.24,"dividendPayoutRate":0.9747780059136532,"dividendFrequency":"Q","dividendGrowthYears":1,"dividendGrowthRate":8.625,"fiveYearAvgDividendRate":0.11642288196229858},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB\",params:#limit:5,,,undefined,":[{"date":"2026-01-30","symbol":"MSB","amount":0.26,"announcedDate":"2026-01-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-30","defaultRemindTime":1769783400000,"name":"美莎比信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-20","payableDate":"2026-01-30","currency":"USD","dateTimestamp":1769749200000,"payDate":"2026-02-20"},{"market":"US","date":"2025-12-12","symbol":"MSB","fiscalQuarterEnding":"2025/10","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1765515600000,"reportTimeType":"post","actualEps":0.21},{"date":"2025-10-30","symbol":"MSB","amount":0.34,"announcedDate":"2025-10-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-30","defaultRemindTime":1761831000000,"name":"美莎比信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-20","payableDate":"2025-10-30","currency":"USD","dateTimestamp":1761796800000,"payDate":"2025-11-20"},{"market":"US","date":"2025-09-15","symbol":"MSB","fiscalQuarterEnding":"2025/07","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1757908800000,"reportTimeType":"post","actualEps":0.36},{"date":"2025-07-30","symbol":"MSB","amount":0.12,"announcedDate":"2025-07-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-30","defaultRemindTime":1753882200000,"name":"美莎比信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-20","payableDate":"2025-07-30","currency":"USD","dateTimestamp":1753848000000,"payDate":"2025-08-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB\",market:\"US\",,,undefined,":[{"executeDate":"2016-04-27","recordDate":"2016-04-30","paymentDate":"2016-05-20","value":0.2,"currency":"USD"},{"executeDate":"2016-07-27","recordDate":"2016-07-30","paymentDate":"2016-08-20","value":0.2,"currency":"USD"},{"executeDate":"2016-10-26","recordDate":"2016-10-30","paymentDate":"2016-11-20","value":0.1,"currency":"USD"},{"executeDate":"2017-01-26","recordDate":"2017-01-30","paymentDate":"2017-02-20","value":0.14,"currency":"USD"},{"executeDate":"2017-04-26","recordDate":"2017-04-30","paymentDate":"2017-05-20","value":0.55,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MSB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MSB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MSB","date":"2026-03-25","current":23.465642,"percent":0.857027,"low":-38.747862,"twenty":4.365351,"median":8.723715,"eighty":21.240964,"high":62.374035,"avg":11.230613,"sd":15.332965,"marketCap":410262712},"quantilePoints":[{"date":"2021-03-26","current":21.406118,"twenty":6.809387,"median":9.286792,"eighty":17.330623,"marketCap":395961901},{"date":"2021-04-01","current":22.611897,"twenty":6.832951,"median":9.303183,"eighty":17.454619,"marketCap":418265918},{"date":"2021-04-09","current":22.356556,"twenty":6.87773,"median":9.356655,"eighty":17.602927,"marketCap":413542715},{"date":"2021-04-16","current":24.824856,"twenty":6.908633,"median":9.375696,"eighty":17.739826,"marketCap":459200350},{"date":"2021-04-23","current":25.399374,"twenty":6.949639,"median":9.406658,"eighty":17.853908,"marketCap":469827558},{"date":"2021-04-30","current":19.852946,"twenty":6.981137,"median":9.439901,"eighty":18.230381,"marketCap":464710754},{"date":"2021-05-07","current":21.472794,"twenty":7.009068,"median":9.46914,"eighty":18.510831,"marketCap":502627583},{"date":"2021-05-14","current":21.276619,"twenty":7.042349,"median":9.504511,"eighty":18.629669,"marketCap":498035579},{"date":"2021-05-21","current":21.702599,"twenty":7.080978,"median":9.532519,"eighty":18.858379,"marketCap":508006787},{"date":"2021-05-28","current":20.861848,"twenty":7.098807,"median":9.572948,"eighty":19.122873,"marketCap":488326772},{"date":"2021-06-04","current":21.450374,"twenty":7.169004,"median":9.615182,"eighty":19.363387,"marketCap":502102782},{"date":"2021-06-11","current":16.342828,"twenty":7.224518,"median":9.643506,"eighty":19.442827,"marketCap":496329978},{"date":"2021-06-18","current":15.133208,"twenty":7.277688,"median":9.663255,"eighty":19.442827,"marketCap":459593950},{"date":"2021-06-25","current":15.651616,"twenty":7.337162,"median":9.689111,"eighty":19.442827,"marketCap":475337962},{"date":"2021-07-02","current":15.552255,"twenty":7.367426,"median":9.703544,"eighty":19.442827,"marketCap":472320360},{"date":"2021-07-09","current":15.707777,"twenty":7.398378,"median":9.712299,"eighty":19.442827,"marketCap":477043563},{"date":"2021-07-16","current":14.731441,"twenty":7.504368,"median":9.732651,"eighty":19.442827,"marketCap":447392341},{"date":"2021-07-23","current":14.956085,"twenty":7.607297,"median":9.748615,"eighty":19.442827,"marketCap":454214746},{"date":"2021-07-30","current":15.016566,"twenty":7.653212,"median":9.761872,"eighty":19.442827,"marketCap":456051547},{"date":"2021-08-06","current":14.584559,"twenty":7.725784,"median":9.784835,"eighty":19.442827,"marketCap":442931537},{"date":"2021-08-13","current":15.431293,"twenty":7.790482,"median":9.806355,"eighty":19.442827,"marketCap":468646757},{"date":"2021-08-20","current":14.221673,"twenty":7.854892,"median":9.828581,"eighty":19.442827,"marketCap":431910729},{"date":"2021-08-27","current":14.321035,"twenty":7.92215,"median":9.862989,"eighty":19.442827,"marketCap":434928331},{"date":"2021-09-03","current":14.269194,"twenty":8.041009,"median":9.874955,"eighty":19.442827,"marketCap":433353930},{"date":"2021-09-10","current":13.975429,"twenty":8.103227,"median":9.884851,"eighty":19.442827,"marketCap":424432323},{"date":"2021-09-17","current":8.207495,"twenty":8.148799,"median":9.884851,"eighty":19.442827,"marketCap":414067515},{"date":"2021-09-24","current":7.666571,"twenty":8.148799,"median":9.884851,"eighty":19.442827,"marketCap":386777894},{"date":"2021-10-01","current":7.817405,"twenty":8.155204,"median":9.884851,"eighty":19.442827,"marketCap":394387500},{"date":"2021-10-08","current":8.909658,"twenty":8.178911,"median":9.884851,"eighty":19.442827,"marketCap":449491542},{"date":"2021-10-15","current":9.31015,"twenty":8.214989,"median":9.884851,"eighty":19.442827,"marketCap":469696358},{"date":"2021-10-22","current":8.00985,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":404096308},{"date":"2021-10-29","current":5.729123,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":289033820},{"date":"2021-11-05","current":5.796739,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":292445022},{"date":"2021-11-12","current":6.249243,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":315273840},{"date":"2021-11-19","current":6.36627,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":321177844},{"date":"2021-11-26","current":6.376673,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":321702645},{"date":"2021-12-03","current":5.960577,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":300710629},{"date":"2021-12-10","current":6.075003,"twenty":8.258056,"median":9.882451,"eighty":19.442827,"marketCap":306483433},{"date":"2021-12-17","current":5.332187,"twenty":8.205856,"median":9.868662,"eighty":19.442827,"marketCap":326950649},{"date":"2021-12-23","current":5.561137,"twenty":8.164698,"median":9.8408,"eighty":19.442827,"marketCap":340989059},{"date":"2021-12-31","current":5.653145,"twenty":8.117366,"median":9.813232,"eighty":19.442827,"marketCap":346630664},{"date":"2022-01-07","current":6.46196,"twenty":8.079042,"median":9.799052,"eighty":19.432897,"marketCap":396224302},{"date":"2022-01-14","current":6.84711,"twenty":7.994949,"median":9.778397,"eighty":19.432897,"marketCap":419840320},{"date":"2022-01-21","current":6.817154,"twenty":7.955658,"median":9.761872,"eighty":19.432897,"marketCap":418003518},{"date":"2022-01-28","current":6.660954,"twenty":7.897147,"median":9.748615,"eighty":19.422967,"marketCap":408425911},{"date":"2022-02-04","current":6.489776,"twenty":7.827807,"median":9.732651,"eighty":19.422967,"marketCap":397929903},{"date":"2022-02-11","current":4.745903,"twenty":7.776707,"median":9.712299,"eighty":19.422967,"marketCap":291001821},{"date":"2022-02-18","current":4.91922,"twenty":7.726264,"median":9.699393,"eighty":19.422967,"marketCap":301629029},{"date":"2022-02-25","current":5.531181,"twenty":7.711346,"median":9.689111,"eighty":19.422967,"marketCap":339152258},{"date":"2022-03-04","current":6.1517,"twenty":7.647338,"median":9.663255,"eighty":19.422967,"marketCap":377200287},{"date":"2022-03-11","current":5.732315,"twenty":7.603169,"median":9.643506,"eighty":19.422967,"marketCap":351485067},{"date":"2022-03-18","current":5.377121,"twenty":7.523215,"median":9.615182,"eighty":19.422967,"marketCap":329705851},{"date":"2022-03-25","current":5.576115,"twenty":7.433751,"median":9.563648,"eighty":19.422967,"marketCap":341907460},{"date":"2022-04-01","current":5.775109,"twenty":7.368615,"median":9.535937,"eighty":19.422967,"marketCap":354109069},{"date":"2022-04-08","current":5.77083,"twenty":7.332363,"median":9.509675,"eighty":19.422967,"marketCap":353846669},{"date":"2022-04-14","current":6.098207,"twenty":7.287197,"median":9.486402,"eighty":19.422967,"marketCap":373920285},{"date":"2022-04-22","current":5.84786,"twenty":7.226533,"median":9.464001,"eighty":19.422967,"marketCap":358569873},{"date":"2022-04-29","current":4.455012,"twenty":7.198978,"median":9.424368,"eighty":19.422967,"marketCap":306352233},{"date":"2022-05-06","current":4.453104,"twenty":7.152308,"median":9.393629,"eighty":19.422967,"marketCap":306221033},{"date":"2022-05-13","current":4.416854,"twenty":7.089761,"median":9.374172,"eighty":19.422967,"marketCap":303728231},{"date":"2022-05-20","current":4.912915,"twenty":7.078951,"median":9.353979,"eighty":19.422967,"marketCap":337840257},{"date":"2022-05-27","current":5.321212,"twenty":7.04177,"median":9.324975,"eighty":19.422967,"marketCap":365917078},{"date":"2022-06-03","current":5.517728,"twenty":7.011445,"median":9.303183,"eighty":19.422967,"marketCap":379430689},{"date":"2022-06-10","current":5.13805,"twenty":6.975788,"median":9.279949,"eighty":19.384666,"marketCap":353321869},{"date":"2022-06-17","current":4.470121,"twenty":6.908633,"median":9.226639,"eighty":18.927889,"marketCap":329837051},{"date":"2022-06-24","current":4.238969,"twenty":6.880108,"median":9.224675,"eighty":18.506575,"marketCap":312781038},{"date":"2022-07-01","current":4.447005,"twenty":6.851932,"median":9.199109,"eighty":17.713807,"marketCap":328131450},{"date":"2022-07-08","current":4.605255,"twenty":6.825712,"median":9.185421,"eighty":16.646163,"marketCap":339808259},{"date":"2022-07-15","current":4.763506,"twenty":6.809387,"median":9.135211,"eighty":16.2641,"marketCap":351485067},{"date":"2022-07-22","current":5.008882,"twenty":6.783832,"median":9.122367,"eighty":16.093709,"marketCap":369590681},{"date":"2022-07-29","current":4.848854,"twenty":6.770758,"median":9.087286,"eighty":15.962485,"marketCap":357782672},{"date":"2022-08-05","current":4.81507,"twenty":6.7312,"median":9.077185,"eighty":15.789928,"marketCap":355289870},{"date":"2022-08-12","current":4.912865,"twenty":6.702414,"median":9.056539,"eighty":15.672261,"marketCap":362505876},{"date":"2022-08-19","current":4.911087,"twenty":6.651769,"median":9.037159,"eighty":15.535838,"marketCap":362374676},{"date":"2022-08-26","current":4.887972,"twenty":6.607594,"median":8.99467,"eighty":15.506601,"marketCap":360669074},{"date":"2022-09-02","current":4.413222,"twenty":6.572859,"median":8.971791,"eighty":15.369203,"marketCap":325638648},{"date":"2022-09-09","current":4.382994,"twenty":6.528191,"median":8.964329,"eighty":15.299099,"marketCap":323408246},{"date":"2022-09-16","current":6.875197,"twenty":6.524127,"median":8.96128,"eighty":15.213561,"marketCap":289952221},{"date":"2022-09-23","current":6.411666,"twenty":6.511588,"median":8.939107,"eighty":15.092305,"marketCap":270403406},{"date":"2022-09-30","current":6.691651,"twenty":6.493183,"median":8.915544,"eighty":14.934585,"marketCap":282211415},{"date":"2022-10-07","current":6.579657,"twenty":6.493183,"median":8.906423,"eighty":14.852659,"marketCap":277488211},{"date":"2022-10-14","current":6.09746,"twenty":6.476584,"median":8.878367,"eighty":14.795244,"marketCap":257152196},{"date":"2022-10-21","current":5.885915,"twenty":6.448716,"median":8.865416,"eighty":14.728849,"marketCap":248230589},{"date":"2022-10-28","current":6.772536,"twenty":6.428184,"median":8.842366,"eighty":14.618912,"marketCap":285622617},{"date":"2022-11-04","current":6.844088,"twenty":6.428184,"median":8.824071,"eighty":14.541197,"marketCap":288640220},{"date":"2022-11-11","current":6.408555,"twenty":6.403577,"median":8.806467,"eighty":14.441489,"marketCap":270272206},{"date":"2022-11-18","current":6.511216,"twenty":6.385082,"median":8.800613,"eighty":14.30151,"marketCap":274601809},{"date":"2022-11-25","current":6.476996,"twenty":6.385082,"median":8.787482,"eighty":14.264298,"marketCap":273158608},{"date":"2022-12-02","current":5.898359,"twenty":6.328985,"median":8.774707,"eighty":14.213645,"marketCap":248755389},{"date":"2022-12-09","current":5.643261,"twenty":6.302262,"median":8.756991,"eighty":14.098055,"marketCap":237996981},{"date":"2022-12-16","current":9.216114,"twenty":6.297004,"median":8.756878,"eighty":13.970245,"marketCap":237472181},{"date":"2022-12-23","current":9.211023,"twenty":6.297004,"median":8.756878,"eighty":13.812658,"marketCap":237340980},{"date":"2022-12-30","current":9.17538,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":236422580},{"date":"2023-01-06","current":9.31795,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":240096183},{"date":"2023-01-13","current":10.081716,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":259776198},{"date":"2023-01-20","current":10.392315,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":267779404},{"date":"2023-01-27","current":12.159161,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":313305838},{"date":"2023-02-03","current":11.074613,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":285360217},{"date":"2023-02-10","current":11.344477,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":292313822},{"date":"2023-02-17","current":12.245721,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":315536240},{"date":"2023-02-24","current":13.834355,"twenty":6.297004,"median":8.756878,"eighty":13.630106,"marketCap":356470671},{"date":"2023-03-03","current":14.190779,"twenty":6.297004,"median":8.756878,"eighty":13.808351,"marketCap":365654678},{"date":"2023-03-10","current":12.917835,"twenty":6.297004,"median":8.756878,"eighty":13.818295,"marketCap":332854653},{"date":"2023-03-17","current":12.378107,"twenty":6.297004,"median":8.756878,"eighty":13.818295,"marketCap":318947443},{"date":"2023-03-24","current":11.970765,"twenty":6.297004,"median":8.756878,"eighty":13.818295,"marketCap":308451435},{"date":"2023-03-31","current":12.821092,"twenty":6.299242,"median":8.756934,"eighty":13.816142,"marketCap":330361851},{"date":"2023-04-06","current":12.64288,"twenty":6.299242,"median":8.756934,"eighty":13.816142,"marketCap":325769848},{"date":"2023-04-14","current":13.106231,"twenty":6.297004,"median":8.756878,"eighty":13.818295,"marketCap":337709057},{"date":"2023-04-21","current":13.080772,"twenty":6.297004,"median":8.756878,"eighty":13.818295,"marketCap":337053056},{"date":"2023-04-28","current":57.060874,"twenty":6.297004,"median":8.756878,"eighty":13.925928,"marketCap":302941030},{"date":"2023-05-05","current":51.994837,"twenty":6.297004,"median":8.756878,"eighty":13.980408,"marketCap":276045010},{"date":"2023-05-12","current":51.648864,"twenty":6.297004,"median":8.756878,"eighty":14.126967,"marketCap":274208209},{"date":"2023-05-19","current":46.953513,"twenty":6.297004,"median":8.756878,"eighty":14.213645,"marketCap":249280190},{"date":"2023-05-26","current":43.91389,"twenty":6.297004,"median":8.756878,"eighty":14.264298,"marketCap":233142577},{"date":"2023-06-02","current":45.446058,"twenty":6.297004,"median":8.756878,"eighty":14.30151,"marketCap":241276983},{"date":"2023-06-09","current":50.264971,"twenty":6.297004,"median":8.756878,"eighty":14.441489,"marketCap":266861003},{"date":"2023-06-16","current":-37.393042,"twenty":6.270379,"median":8.735647,"eighty":14.480013,"marketCap":271584207},{"date":"2023-06-23","current":-37.031757,"twenty":6.247683,"median":8.721221,"eighty":14.486061,"marketCap":268960205},{"date":"2023-06-30","current":-36.941435,"twenty":6.218808,"median":8.716855,"eighty":14.492109,"marketCap":268304204},{"date":"2023-07-07","current":-35.496294,"twenty":6.210234,"median":8.705156,"eighty":14.492109,"marketCap":257808196},{"date":"2023-07-14","current":-35.189201,"twenty":6.181218,"median":8.685564,"eighty":14.492109,"marketCap":255577794},{"date":"2023-07-21","current":-32.60601,"twenty":6.154061,"median":8.674365,"eighty":14.492109,"marketCap":236816180},{"date":"2023-07-28","current":-33.129874,"twenty":6.097609,"median":8.661292,"eighty":14.492109,"marketCap":240620983},{"date":"2023-08-04","current":-33.039553,"twenty":6.075523,"median":8.653322,"eighty":14.492109,"marketCap":239964982},{"date":"2023-08-11","current":-33.382774,"twenty":6.020032,"median":8.643963,"eighty":14.492109,"marketCap":242457784},{"date":"2023-08-18","current":-35.171137,"twenty":5.987797,"median":8.629945,"eighty":14.492109,"marketCap":255446594},{"date":"2023-08-25","current":-34.520823,"twenty":5.943601,"median":8.624946,"eighty":14.492109,"marketCap":250723391},{"date":"2023-09-01","current":-33.292452,"twenty":5.909129,"median":8.610547,"eighty":14.492109,"marketCap":241801784},{"date":"2023-09-08","current":-35.514358,"twenty":5.894041,"median":8.601908,"eighty":14.492109,"marketCap":257939396},{"date":"2023-09-15","current":39.702173,"twenty":5.872677,"median":8.585815,"eighty":14.527756,"marketCap":269091405},{"date":"2023-09-22","current":38.42458,"twenty":5.872677,"median":8.585815,"eighty":14.60041,"marketCap":260432198},{"date":"2023-09-29","current":39.469884,"twenty":5.872677,"median":8.585815,"eighty":14.726257,"marketCap":267517003},{"date":"2023-10-06","current":38.889159,"twenty":5.872677,"median":8.585815,"eighty":14.790701,"marketCap":263581000},{"date":"2023-10-13","current":39.489241,"twenty":5.872677,"median":8.585815,"eighty":14.849843,"marketCap":267648204},{"date":"2023-10-20","current":41.173341,"twenty":5.872677,"median":8.585815,"eighty":14.911002,"marketCap":279062612},{"date":"2023-10-27","current":39.973178,"twenty":5.862589,"median":8.583863,"eighty":14.969045,"marketCap":270928206},{"date":"2023-11-03","current":39.450526,"twenty":5.862589,"median":8.583863,"eighty":15.136664,"marketCap":267385803},{"date":"2023-11-10","current":36.81791,"twenty":5.862589,"median":8.583863,"eighty":15.287127,"marketCap":249542590},{"date":"2023-11-17","current":36.604978,"twenty":5.862589,"median":8.583863,"eighty":15.318107,"marketCap":248099389},{"date":"2023-11-24","current":37.805141,"twenty":5.862589,"median":8.583863,"eighty":15.431138,"marketCap":256233795},{"date":"2023-12-01","current":34.746661,"twenty":5.862589,"median":8.586662,"eighty":15.515483,"marketCap":235504179},{"date":"2023-12-08","current":35.753249,"twenty":5.866073,"median":8.601908,"eighty":15.571263,"marketCap":242326584},{"date":"2023-12-15","current":23.302471,"twenty":5.866073,"median":8.622066,"eighty":15.716949,"marketCap":262793800},{"date":"2023-12-22","current":23.965596,"twenty":5.866073,"median":8.629106,"eighty":15.869403,"marketCap":270272206},{"date":"2023-12-29","current":23.442076,"twenty":5.862589,"median":8.635662,"eighty":15.962485,"marketCap":264368201},{"date":"2024-01-05","current":22.965091,"twenty":5.859106,"median":8.645105,"eighty":16.033222,"marketCap":258988997},{"date":"2024-01-12","current":23.45371,"twenty":5.859106,"median":8.653322,"eighty":16.214685,"marketCap":264499401},{"date":"2024-01-19","current":24.396046,"twenty":5.855622,"median":8.653322,"eighty":16.42527,"marketCap":275126609},{"date":"2024-01-26","current":24.291342,"twenty":5.859106,"median":8.653322,"eighty":17.232219,"marketCap":273945808},{"date":"2024-02-02","current":22.93019,"twenty":5.859106,"median":8.671616,"eighty":18.310814,"marketCap":258595397},{"date":"2024-02-09","current":21.522502,"twenty":5.859106,"median":8.679621,"eighty":18.769009,"marketCap":242720185},{"date":"2024-02-16","current":22.046022,"twenty":5.859106,"median":8.680764,"eighty":19.363387,"marketCap":248624189},{"date":"2024-02-23","current":20.929179,"twenty":5.859106,"median":8.680764,"eighty":19.442827,"marketCap":236028979},{"date":"2024-03-01","current":20.254419,"twenty":5.862589,"median":8.683164,"eighty":19.631496,"marketCap":228419374},{"date":"2024-03-08","current":21.429431,"twenty":5.862589,"median":8.683164,"eighty":19.678308,"marketCap":241670584},{"date":"2024-03-15","current":20.207884,"twenty":5.862589,"median":8.704624,"eighty":19.825839,"marketCap":227894573},{"date":"2024-03-22","current":22.290331,"twenty":5.862589,"median":8.712805,"eighty":19.906697,"marketCap":251379391},{"date":"2024-03-28","current":20.615066,"twenty":5.862589,"median":8.717064,"eighty":19.947775,"marketCap":232486577},{"date":"2024-04-05","current":20.766306,"twenty":5.859106,"median":8.713303,"eighty":20.0096,"marketCap":234192178},{"date":"2024-04-12","current":20.254419,"twenty":5.859106,"median":8.713303,"eighty":20.055646,"marketCap":228419374},{"date":"2024-04-19","current":19.85887,"twenty":5.859106,"median":8.713303,"eighty":20.074831,"marketCap":223958570},{"date":"2024-04-26","current":11.928956,"twenty":5.862589,"median":8.721024,"eighty":20.117816,"marketCap":226451372},{"date":"2024-05-03","current":11.645591,"twenty":5.862589,"median":8.747115,"eighty":20.117816,"marketCap":221072168},{"date":"2024-05-10","current":11.528098,"twenty":5.862589,"median":8.779066,"eighty":20.117816,"marketCap":218841766},{"date":"2024-05-17","current":12.215776,"twenty":5.862589,"median":8.887537,"eighty":20.117816,"marketCap":231896176},{"date":"2024-05-24","current":11.94969,"twenty":5.862589,"median":9.049567,"eighty":20.117816,"marketCap":226844972},{"date":"2024-05-31","current":11.859842,"twenty":5.862589,"median":9.063156,"eighty":20.117816,"marketCap":225139371},{"date":"2024-06-07","current":12.184675,"twenty":5.862589,"median":9.102665,"eighty":20.117816,"marketCap":231305776},{"date":"2024-06-14","current":10.309287,"twenty":5.859106,"median":9.17538,"eighty":20.119317,"marketCap":221072168},{"date":"2024-06-21","current":10.645792,"twenty":5.855622,"median":9.200439,"eighty":20.120818,"marketCap":228288174},{"date":"2024-06-28","current":10.700856,"twenty":5.850427,"median":9.211511,"eighty":20.133396,"marketCap":229468974},{"date":"2024-07-05","current":10.817104,"twenty":5.850427,"median":9.246665,"eighty":20.133396,"marketCap":231961776},{"date":"2024-07-12","current":10.572373,"twenty":5.850427,"median":9.31015,"eighty":20.133396,"marketCap":226713772},{"date":"2024-07-15","current":10.676383,"twenty":5.850427,"median":9.31015,"eighty":20.133396,"marketCap":228944174},{"date":"2024-08-02","current":10.639674,"twenty":5.828602,"median":9.379742,"eighty":20.19625,"marketCap":228156973},{"date":"2024-08-09","current":10.05232,"twenty":5.828602,"median":9.526988,"eighty":20.19625,"marketCap":215561764},{"date":"2024-08-16","current":10.284814,"twenty":5.828602,"median":9.589821,"eighty":20.19625,"marketCap":220547368},{"date":"2024-08-23","current":10.86605,"twenty":5.828602,"median":9.656301,"eighty":20.19625,"marketCap":233011377},{"date":"2024-08-30","current":10.419416,"twenty":5.828602,"median":9.675118,"eighty":20.19625,"marketCap":223433770},{"date":"2024-09-06","current":10.609082,"twenty":5.828602,"median":9.698882,"eighty":20.19625,"marketCap":227500973},{"date":"2024-09-13","current":15.335191,"twenty":5.828602,"median":9.716249,"eighty":20.19625,"marketCap":270797006},{"date":"2024-09-20","current":16.159903,"twenty":5.828602,"median":9.747943,"eighty":20.19625,"marketCap":285360217},{"date":"2024-09-27","current":17.920775,"twenty":5.828602,"median":9.762249,"eighty":20.19625,"marketCap":316454641},{"date":"2024-10-04","current":17.110923,"twenty":5.828602,"median":9.791031,"eighty":20.19625,"marketCap":302153830},{"date":"2024-10-11","current":18.017363,"twenty":5.828602,"median":9.831688,"eighty":20.19625,"marketCap":318160242},{"date":"2024-10-18","current":19.10955,"twenty":5.828602,"median":9.892565,"eighty":20.19625,"marketCap":337446657},{"date":"2024-10-25","current":18.478013,"twenty":5.828602,"median":10.067018,"eighty":20.19625,"marketCap":326294648},{"date":"2024-10-31","current":17.70531,"twenty":5.828602,"median":10.247199,"eighty":20.19625,"marketCap":312649838},{"date":"2024-11-08","current":19.488472,"twenty":5.825777,"median":10.328667,"eighty":20.198577,"marketCap":344137862},{"date":"2024-11-15","current":19.176419,"twenty":5.825777,"median":10.40718,"eighty":20.198577,"marketCap":338627458},{"date":"2024-11-22","current":19.718797,"twenty":5.825777,"median":10.509425,"eighty":20.198577,"marketCap":348205065},{"date":"2024-11-29","current":20.625237,"twenty":5.825777,"median":10.554018,"eighty":20.208641,"marketCap":364211477},{"date":"2024-12-06","current":19.949122,"twenty":5.825777,"median":10.578491,"eighty":20.254419,"marketCap":352272268},{"date":"2024-12-13","current":19.55534,"twenty":5.825777,"median":10.645792,"eighty":20.254419,"marketCap":345318663},{"date":"2024-12-20","current":4.190214,"twenty":5.776821,"median":10.645792,"eighty":20.254419,"marketCap":385072293},{"date":"2024-12-27","current":4.083139,"twenty":5.768943,"median":10.645792,"eighty":20.254419,"marketCap":375232286},{"date":"2025-01-03","current":4.038881,"twenty":5.731677,"median":10.645792,"eighty":20.254419,"marketCap":371165082},{"date":"2025-01-10","current":3.816165,"twenty":5.713799,"median":10.658029,"eighty":20.254419,"marketCap":350697867},{"date":"2025-01-17","current":4.095988,"twenty":5.678286,"median":10.658029,"eighty":20.254419,"marketCap":376413086},{"date":"2025-01-24","current":4.442912,"twenty":5.654429,"median":10.658029,"eighty":20.254419,"marketCap":408294711},{"date":"2025-01-31","current":3.600586,"twenty":5.616769,"median":10.658029,"eighty":20.254419,"marketCap":330886652},{"date":"2025-02-07","current":3.570605,"twenty":5.596228,"median":10.658029,"eighty":20.254419,"marketCap":328131450},{"date":"2025-02-14","current":3.589165,"twenty":5.561137,"median":10.658029,"eighty":20.254419,"marketCap":329837051},{"date":"2025-02-21","current":4.63422,"twenty":5.552578,"median":10.658029,"eighty":20.254419,"marketCap":425875524},{"date":"2025-02-28","current":4.061724,"twenty":5.531426,"median":10.658029,"eighty":20.254419,"marketCap":373264284},{"date":"2025-03-07","current":3.562039,"twenty":5.493094,"median":10.670265,"eighty":20.254419,"marketCap":327344249},{"date":"2025-03-14","current":3.661976,"twenty":5.442781,"median":10.670265,"eighty":20.254419,"marketCap":336528256},{"date":"2025-03-21","current":3.998906,"twenty":5.442781,"median":10.670265,"eighty":20.254419,"marketCap":367491480},{"date":"2025-03-28","current":3.856139,"twenty":5.405365,"median":10.670265,"eighty":20.254419,"marketCap":354371470},{"date":"2025-04-04","current":3.673397,"twenty":5.360747,"median":10.670265,"eighty":20.254419,"marketCap":337577857},{"date":"2025-04-11","current":3.643416,"twenty":5.327797,"median":10.658029,"eighty":20.254419,"marketCap":334822655},{"date":"2025-04-17","current":3.80046,"twenty":5.306926,"median":10.658029,"eighty":20.254419,"marketCap":349254666},{"date":"2025-04-25","current":3.856913,"twenty":5.195406,"median":10.670265,"eighty":20.254419,"marketCap":359750674},{"date":"2025-05-02","current":3.840034,"twenty":5.123168,"median":10.670265,"eighty":20.254419,"marketCap":358176273},{"date":"2025-05-09","current":3.885045,"twenty":5.078195,"median":10.670265,"eighty":20.254419,"marketCap":362374676},{"date":"2025-05-16","current":3.575592,"twenty":5.017061,"median":10.670265,"eighty":20.254419,"marketCap":333510654},{"date":"2025-05-23","current":3.585438,"twenty":4.981646,"median":10.670265,"eighty":20.254419,"marketCap":334429054},{"date":"2025-05-30","current":3.56012,"twenty":4.947731,"median":10.670265,"eighty":20.254419,"marketCap":332067453},{"date":"2025-06-06","current":3.683901,"twenty":4.911798,"median":10.670265,"eighty":20.254419,"marketCap":343613061},{"date":"2025-06-13","current":3.741285,"twenty":4.855542,"median":10.670265,"eighty":20.254419,"marketCap":349517066},{"date":"2025-06-20","current":3.370527,"twenty":4.827873,"median":10.670265,"eighty":20.254419,"marketCap":314880240},{"date":"2025-06-27","current":3.311543,"twenty":4.761406,"median":10.670265,"eighty":20.254419,"marketCap":309369835},{"date":"2025-07-03","current":3.510966,"twenty":4.740135,"median":10.670265,"eighty":20.254419,"marketCap":328000250},{"date":"2025-07-11","current":3.473047,"twenty":4.726695,"median":10.670265,"eighty":20.254419,"marketCap":324457847},{"date":"2025-07-18","current":3.613486,"twenty":4.69441,"median":10.670265,"eighty":20.254419,"marketCap":337577857},{"date":"2025-07-25","current":3.982839,"twenty":4.619882,"median":10.670265,"eighty":20.254419,"marketCap":372083483},{"date":"2025-08-01","current":4.109234,"twenty":4.59921,"median":10.670265,"eighty":20.254419,"marketCap":383891492},{"date":"2025-08-08","current":4.062889,"twenty":4.498513,"median":10.670265,"eighty":20.254419,"marketCap":379561889},{"date":"2025-08-15","current":4.364832,"twenty":4.453486,"median":10.670265,"eighty":20.254419,"marketCap":407769910},{"date":"2025-08-22","current":4.548807,"twenty":4.453486,"median":10.670265,"eighty":20.254419,"marketCap":424957123},{"date":"2025-08-29","current":4.367641,"twenty":4.443375,"median":10.670265,"eighty":20.254419,"marketCap":408032311},{"date":"2025-09-05","current":4.41539,"twenty":4.425668,"median":10.670265,"eighty":20.254419,"marketCap":412493114},{"date":"2025-09-12","current":4.487014,"twenty":4.415683,"median":10.61629,"eighty":20.254419,"marketCap":419184319},{"date":"2025-09-19","current":4.302261,"twenty":4.401679,"median":10.572373,"eighty":20.254419,"marketCap":399110704},{"date":"2025-09-26","current":4.150933,"twenty":4.38646,"median":10.535663,"eighty":20.254419,"marketCap":385072293},{"date":"2025-10-03","current":4.555419,"twenty":4.379438,"median":10.419416,"eighty":20.254419,"marketCap":422595522},{"date":"2025-10-10","current":4.389947,"twenty":4.374156,"median":10.349056,"eighty":20.254419,"marketCap":407245110},{"date":"2025-10-17","current":4.340447,"twenty":4.367859,"median":10.278696,"eighty":20.254419,"marketCap":402653106},{"date":"2025-10-24","current":5.057491,"twenty":4.367859,"median":10.104629,"eighty":20.254419,"marketCap":469171557},{"date":"2025-10-31","current":4.937276,"twenty":4.367859,"median":9.689649,"eighty":20.254419,"marketCap":458019549},{"date":"2025-11-07","current":4.843933,"twenty":4.367859,"median":9.532858,"eighty":20.254419,"marketCap":449360342},{"date":"2025-11-14","current":4.82979,"twenty":4.367859,"median":9.324452,"eighty":20.254419,"marketCap":448048341},{"date":"2025-11-21","current":4.747762,"twenty":4.367859,"median":9.246665,"eighty":20.254419,"marketCap":440438735},{"date":"2025-11-28","current":4.518647,"twenty":4.365351,"median":9.205931,"eighty":20.254419,"marketCap":419184319},{"date":"2025-12-05","current":4.747762,"twenty":4.365351,"median":9.129554,"eighty":20.254419,"marketCap":440438735},{"date":"2025-12-12","current":4.995262,"twenty":4.365351,"median":8.723715,"eighty":20.254419,"marketCap":463398753},{"date":"2025-12-19","current":26.614198,"twenty":4.365351,"median":8.723715,"eighty":20.282617,"marketCap":458019549},{"date":"2025-12-26","current":27.460425,"twenty":4.365351,"median":8.723715,"eighty":20.302476,"marketCap":472582760},{"date":"2026-01-02","current":29.36634,"twenty":4.365351,"median":8.723715,"eighty":20.36843,"marketCap":505382785},{"date":"2026-01-09","current":31.371362,"twenty":4.365351,"median":8.723715,"eighty":20.404151,"marketCap":539888411},{"date":"2026-01-16","current":30.982556,"twenty":4.365351,"median":8.723715,"eighty":20.506673,"marketCap":533197206},{"date":"2026-01-23","current":27.841608,"twenty":4.365351,"median":8.723715,"eighty":20.582715,"marketCap":479142765},{"date":"2026-01-30","current":25.63837,"twenty":4.365351,"median":8.723715,"eighty":20.623235,"marketCap":441225936},{"date":"2026-02-06","current":26.26351,"twenty":4.365351,"median":8.723715,"eighty":20.696503,"marketCap":451984344},{"date":"2026-02-13","current":25.943316,"twenty":4.365351,"median":8.723715,"eighty":20.763979,"marketCap":446473940},{"date":"2026-02-20","current":25.188574,"twenty":4.365351,"median":8.723715,"eighty":20.867453,"marketCap":433485130},{"date":"2026-02-27","current":23.671465,"twenty":4.365351,"median":8.723715,"eighty":20.922568,"marketCap":407376310},{"date":"2026-03-06","current":23.183551,"twenty":4.365351,"median":8.723715,"eighty":20.982694,"marketCap":398979504},{"date":"2026-03-13","current":24.38809,"twenty":4.365351,"median":8.723715,"eighty":21.023964,"marketCap":419709119},{"date":"2026-03-20","current":23.053949,"twenty":4.365351,"median":8.723715,"eighty":21.091972,"marketCap":396749102},{"date":"2026-03-25","current":23.839186,"twenty":4.365351,"median":8.723715,"eighty":21.240964,"marketCap":410262712}],"updateTime":1774583963070},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606622734","title":"Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2606622734","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606622734?lang=en_us&edition=fundamental","pubTime":"2026-01-27 07:45","pubTimestamp":1769471100,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan.  26, 2026  (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on use of Ryo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/26/3226046/0/en/Real-World-Commercial-Experience-with-Ryoncil-Shows-84-Survival-of-Children-with-SR-aGvHD-After-Completing-28-Days-of-Treatment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003077747.HKD","BK4197","LU0661504455.SGD","LU0949170772.SGD","BK4575","LU0545039389.USD","MSC","LU1894683264.USD","LU2500361329.USD","LU0738911758.USD","BK4588","BK4585","BK4208","BK4139","LU1894683348.USD","LU2346227817.USD","SR","CMS","BK4006","LU2637428348.USD","LU0553294199.USD","MESO","MSB","BK4150"],"gpt_icon":0},{"id":"2605498182","title":"Mesoblast (ASX:MSB) Is Down 6.4% After Encouraging FDA Feedback On Back Pain Cell Therapy Data – Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2605498182","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605498182?lang=en_us&edition=fundamental","pubTime":"2026-01-22 13:29","pubTimestamp":1769059783,"startTime":"0","endTime":"0","summary":"In January 2026, Mesoblast reported that the FDA’s review of Phase 3 data for its cell therapy rexlemestrocel-L in chronic discogenic low back pain found pain outcomes favoring the active treatment and confirmed that 12‑month pain reduction could support a future Biologics License Application.\nThe FDA also indicated that robust opioid reduction data from Mesoblast’s trial might be reflected in product labeling, highlighting the therapy’s potential relevance to chronic pain management during...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-down-64-after-encouraging-fda-feedback-o","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-down-64-after-encouraging-fda-feedback-o","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB","MSB.AU","BK7508","BK7501","BK7067","BK4006"],"gpt_icon":0},{"id":"2605608122","title":"Mesoblast (ASX:MSB) Valuation Check After FDA Backs Rexlemestrocel L’s Pain And Opioid Reduction Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2605608122","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605608122?lang=en_us&edition=fundamental","pubTime":"2026-01-21 08:47","pubTimestamp":1768956470,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) is back in focus after feedback from the U.S. FDA on its rexlemestrocel L cell therapy, which targets chronic discogenic low back pain and is directly linked to opioid use reduction.\nSee our latest analysis for Mesoblast.\nDespite the positive FDA feedback, Mesoblast’s recent share price momentum has been soft, with a 7 day share price return of a 7.0% decline and a 30 day share price return of a 12.7% decline, while the 3 year total shareholder return of 177.6% points to a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-after-fda-backs-rexlemestro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-after-fda-backs-rexlemestro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK4006","MSB","MSB.AU","DCF","BK7508","BK7501"],"gpt_icon":0},{"id":"2605146306","title":"Mesabi Trust Down Over 11%, on Pace for Largest Percent Decrease Since February 2025 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2605146306","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605146306?lang=en_us&edition=fundamental","pubTime":"2026-01-21 03:57","pubTimestamp":1768939020,"startTime":"0","endTime":"0","summary":"Mesabi Trust  is currently at $36.19, down $4.77 or 11.65%. --Would be lowest close since Dec. 24, 2025, when it closed at $36.02. --On pace for largest percent decrease since Feb. 21, 2025, when it fell 12.75%. --Down 35.88% from its all-time closing high of $56.44 on Dec. 13, 2010. --Up 20.07% from 52 weeks ago , when it closed at $30.14. --Down 12.06% from its 52-week closing high of $41.15 on Jan. 8, 2026. --Up 59.21% from its 52-week closing low of $22.73 on June 25, 2025. --Traded as low as $35.00; lowest intraday level since Dec. 22, 2025, when it hit $34.51. --Down 14.55% at today's intraday low; largest intraday percent decrease since Jan. 30, 2025, when it fell as much as 31.49%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB","BK4006"],"gpt_icon":0},{"id":"2604196159","title":"Press Release: Mesabi Trust Press Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2604196159","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604196159?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:05","pubTimestamp":1768597500,"startTime":"0","endTime":"0","summary":"The Trustees of Mesabi Trust  declared a distribution of twenty-six cents  per Unit of Beneficial Interest payable on February 20, 2026 to Mesabi Trust Unitholders of record at the close of business on January 30, 2026. This compares to a five dollar ninety-five cents  per Unit distribution declared for the same period last year.Quarterly royalty payments from Cliffs and Northshore for iron ore production and shipments during the third calendar quarter, which are payable to Mesabi Trust under the royalty agreement, are due January 30, 2026, together with the quarterly royalty report. After receiving the quarterly royalty report and payment, Mesa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB","BK4006"],"gpt_icon":0},{"id":"2603143675","title":"Does Mesoblast’s New Board Leadership After First FDA Approval Change The Bull Case For ASX:MSB?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603143675","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603143675?lang=en_us&edition=fundamental","pubTime":"2026-01-15 09:34","pubTimestamp":1768440853,"startTime":"0","endTime":"0","summary":"In early January 2026, Mesoblast Limited implemented a series of board changes, appointing Philip Facchina as non-executive Chair and Lyn Cobley as Chair of the Audit and Risk Committee, while former Chair Jane Bell retired from that role but remained on the board.\nThese governance shifts come as Mesoblast moves further into a revenue-generating commercial phase following its first U.S. FDA approval, highlighting an effort to align board oversight with the company’s next stage of corporate...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/does-mesoblasts-new-board-leadership-after-first-fda-approva","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/does-mesoblasts-new-board-leadership-after-first-fda-approva","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7508","BK4006","BK7501","MSB","MSB.AU"],"gpt_icon":0},{"id":"2602582376","title":"New Crypto Exchange BitGW Offers Secure and Compliant Trading: Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2602582376","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602582376?lang=en_us&edition=fundamental","pubTime":"2026-01-10 08:07","pubTimestamp":1768003620,"startTime":"0","endTime":"0","summary":"In 2026, employing AI instruments in cryptocurrency exchange businesses becomes a dominant trend. BitGW, a U.S.-licensed centralized crypto trading platform, leverages it to enhance the cryptocurrency","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/reviews/new-crypto-exchange-bitgw-offers-secure-and-compliant-trading-review","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/reviews/new-crypto-exchange-bitgw-offers-secure-and-compliant-trading-review","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["TON.USD.CC","APT.USD.HKCC","BK4601","MSB.AU","BK7501","BK4157","TON.USD.HKCC","METHmain","BTC","BK4006","ETH.USD.CC","BK7105","BK7016","BTC.USD.HKCC","APT.USD.CC","BTC.AU","ETH","SOL.AU","LINK","ETHU","ADA.AU","BK7083","BK7508","ETH.USD.HKCC","MSB","BK7067"],"gpt_icon":0},{"id":"2602729863","title":"Mesoblast (ASX:MSB) Valuation Check As Leadership Changes And Debt Refinancing Reset Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2602729863","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602729863?lang=en_us&edition=fundamental","pubTime":"2026-01-09 17:34","pubTimestamp":1767951288,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) is back in focus after a cluster of late December and early January announcements, including new board leadership, fresh credit arrangements with an existing director, and sizable shelf registrations in both ordinary shares and ADSs.\nSee our latest analysis for Mesoblast.\nThe recent board reshuffle, fresh credit facility and large shelf registrations appear to have caught the market’s eye, with a 1-day share price return of 4.07% and a 7-day share price return of 10.83%...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-as-leadership-changes-and-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-as-leadership-changes-and-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4006","BK7508","MSB","DCF","BK7501","MSB.AU","BK7067"],"gpt_icon":0},{"id":"2601893174","title":"Malaysian Shares End in Red Bucking Regional Gains; MSB Global's Shares Rally 18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601893174","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601893174?lang=en_us&edition=fundamental","pubTime":"2026-01-06 17:51","pubTimestamp":1767693071,"startTime":"0","endTime":"0","summary":"Malaysian stocks dropped slightly on Tuesday, snapping yesterday's gains, and bucking a positive regional trend.The FTSE Bursa Malaysia KLCI shed 7.97 points to end 0.5% lower at 1,672.35. The day range was between 1,667.82 and 1,679.26.In corporate news, shares of MSB Global Group  jumped about 18% in close after its unit MSB Machinery Corporation  signed a joint venture deal with Thai Sin Anant Rubber Factory  to establish a new JV in Thailand.Whereas, shares of Sarawak Consolidated Industries  slid about 3% on Tuesday's close after it signed a development deal to undertake a residential and commercial project in Sarawak, Malaysia, through its unit SCIB Development.Shares of Infoline Tec Group  dropped over 1% on close after its unit Infoline IT Solutions secured a deal from Niaga Sari for a sub-contract worth 9.7 million ringgit on a 30-story serviced apartment project in Terengganu, Malaysia.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MSB","BK4006"],"gpt_icon":0},{"id":"2601865699","title":"MSB Global Unit, Thai Sin Anant Form Auto Parts JV in Thailand; Shares Rally 18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601865699","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601865699?lang=en_us&edition=fundamental","pubTime":"2026-01-06 13:24","pubTimestamp":1767677048,"startTime":"0","endTime":"0","summary":"MSB Global Group  unit MSB Machinery Corporation  signed a joint venture deal with Thai Sin Anant Rubber Factory  to establish a new JV in Thailand, according to a Monday Malaysian bourse filing.Shares of the automotive products manufacturer jumped about 18% in Tuesday's midday trade.The JV will be owned 81% by Thai Sin Anant Rubber Factory , and 19% by MSB Machinery Corporation .The JV will see the sole distributor of \"Gold Series\" automotive parts in Thailand, focusing on suspension components, shock absorbers and related parts, the filing said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MSB","BK4006"],"gpt_icon":0},{"id":"2600034377","title":"Press Release: Mesoblast Announces Changes to Board of Directors' Leadership Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2600034377","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600034377?lang=en_us&edition=fundamental","pubTime":"2026-01-02 07:02","pubTimestamp":1767308520,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan. 01, 2026  -- Mesoblast Limited , global leader in allogeneic cellular medicines for inflammatory diseases, today announced that as foreshadowed at the recent Annual General Meeting the Board will undertake a number of changes in line with the Company's evolution to a revenue-generating commercial company.Having presided during the most transformational period for the company with its first U.S. Food & Drug Administration  approval and successful product commercialization, Ms Jane Bell will retire from her role as Chair and will remain on the Board as a non-executive director. The Board has unanimously appointed Mr Philip Facchina to the role of non-executive Chair and Ms Lyn Cobley as Chair of the Audit and Risk Committee. Mr William Burns remains as Mesoblast Vice-Chair and Chair of the Nomination and Remuneration Committee.Mr Facchina joined the Mesoblast board in March 2021 and has over forty years of experience in corporate strategy, finance, and business development","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","MSB.AU","BK7501","MSB","BK4139","BK4150","BK4575","MSC","R","BK4232","MESO","BK4006","BK7508","BK7067"],"gpt_icon":0},{"id":"2595759386","title":"Press Release: Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line","url":"https://stock-news.laohu8.com/highlight/detail?id=2595759386","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595759386?lang=en_us&edition=fundamental","pubTime":"2025-12-30 07:57","pubTimestamp":1767052620,"startTime":"0","endTime":"0","summary":"Mesoblast has option to draw down up to US$125 million by June 30, 2026. New facility does not encumber any of Mesoblast's material assets or intellectual property. The new credit-line has a fixed interest rate of 8.00% per annum, a substantial reduction from Mesoblast's current debt facilities, with a five-year interest only period. The initial US$75 million drawn is unsecured until the remainder of the NovaQuest debt is repaid, no later than July 8, 2026, after which the entire new facility  will be secured solely with the Temcell royalty.Mesoblast's Ryoncil  for the treatment of steroid-refractory acute graft versus host disease  in pediatric patients 2 months and older is the first FDA-approved mesenchymal stromal cell  therapy. Please see the full Prescribing Information at www.ryo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","MESO","BK4022","R","BK7508","MSC","BK7501","BK4139","MSB.AU","MSB","BK4150","BK7067","BK4006","BK4575"],"gpt_icon":0},{"id":"2591829670","title":"Aspire Announces Major Australia, EU and US Regulatory Milestones, Marking a New Chapter in Its Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2591829670","media":"prnewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591829670?lang=en_us&edition=fundamental","pubTime":"2025-12-16 12:23","pubTimestamp":1765858980,"startTime":"0","endTime":"0","summary":"SINGAPORE, Dec. 16, 2025 /PRNewswire/ -- Aspire, the Singapore-headquartered fintech, today announced a series of regulatory milestones marking a major step in its global expansion. Over the past year alone, the company has secured eight licenses and registrations, strengthening its footprint across Australia, Europe and the United States and laying the foundation for its next phase of growth in some of the world's most important financial hubs.In Australia, Aspire has been granted a full Australian Financial Services License . This strengthens its presence in Asia Pacific and enables the company to deliver its financial stack to Australian businesses directly. With the new license, Aspire will bring its full financial stack, including multicurrency accounts, payments, cards and spend, to Australian companies that increasingly expect a modern, integrated finance platform.2025 has been a defining year for Aspire, from securing major licenses to deepening its footprint in Asia. The compa","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2752414/Aspire_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2752414/Aspire_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/aspire-announces-major-australia-eu-and-us-regulatory-milestones-marking-a-new-chapter-in-its-global-expansion-302642993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XJO.AU","LU0545039389.USD","BK4585","SEC.AU","BK7508","LU0661504455.SGD","BK4588","EMI","BK7501","XAO.AU","LU0553294199.USD","LU0949170772.SGD","BK4208","LU1003077747.HKD","LU2346227817.USD","BK7067","BK4006","XKO.AU","MSB","LU0738911758.USD","LU1894683348.USD","MSB.AU","LU1894683264.USD","LU2637428348.USD","BK4156","LU2500361329.USD","CMS"],"gpt_icon":0},{"id":"2590547736","title":"Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD","url":"https://stock-news.laohu8.com/highlight/detail?id=2590547736","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590547736?lang=en_us&edition=fundamental","pubTime":"2025-12-12 07:22","pubTimestamp":1765495320,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec.  11, 2025  (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that an independent pe","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3204384/0/en/Independent-Study-Presented-at-American-Society-of-Hematology-ASH-Annual-Meeting-Concludes-Remestemcel-L-Superior-to-Ruxolitinib-in-Clinical-Outcomes-as-Treatment-for-SR-aGvHD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4197","BK4117","BK4109","BK4139","BK4107","MESO","BK4150","BK4575","SR","ASH","SPN","MSC","LU2463526074.USD","BK4006","MSB","AFG"],"gpt_icon":0},{"id":"2590541654","title":"Is Mesoblast (ASX:MSB) Using High-Profile Conferences To Recast Its Core Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590541654","media":"Simply Wall St.","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590541654?lang=en_us&edition=fundamental","pubTime":"2025-12-11 22:33","pubTimestamp":1765463582,"startTime":"0","endTime":"0","summary":"Mesoblast Limited recently presented at the Piper Sandler 37th Annual Healthcare Conference in New York, led by Founder and CEO Silviu Itescu.\nThe CEO’s direct participation in this high-profile healthcare forum positioned Mesoblast to highlight its scientific direction, clinical priorities, and broader corporate story to an influential audience.\nWe’ll now examine how Mesoblast’s high-profile conference appearance with direct CEO participation may influence the company’s broader investment...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/is-mesoblast-asxmsb-using-high-profile-conferences-to-recast","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/is-mesoblast-asxmsb-using-high-profile-conferences-to-recast","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","MSB.AU","BK7508","BK7067","BK4006","MSB"],"gpt_icon":0},{"id":"2590574534","title":"Mesoblast (ASX:MSB) Valuation Check as Investors Eye Piper Sandler Healthcare Conference Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2590574534","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590574534?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:27","pubTimestamp":1765373230,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) steps into the spotlight this week as CEO Silviu Itescu presents at the Piper Sandler 37th Annual Healthcare Conference, and traders are watching for fresh color on strategy and late stage trials.\nSee our latest analysis for Mesoblast.\nThat anticipation has arrived on the back of a strong near term rebound, with a 1 month share price return of 27.03 percent and a 1 year total shareholder return of 65.88 percent, even though the year to date share price return remains...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-as-investors-eye-piper-sand","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-as-investors-eye-piper-sand","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","BK4585","BK4137","ISBC","BK4588","BK7067","BK7501","MSB","BK4211","MSB.AU","LABU","DCF","BK4006","LU0128526141.USD","XLV","LU0029874061.USD","XBI","HCSG","BK7508"],"gpt_icon":0},{"id":"2590041013","title":"Matrixport Appoints Dominik Oggenfuss as Chief Executive Officer of Matrixport Asset Management AG","url":"https://stock-news.laohu8.com/highlight/detail?id=2590041013","media":"prnewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590041013?lang=en_us&edition=fundamental","pubTime":"2025-12-10 16:00","pubTimestamp":1765353600,"startTime":"0","endTime":"0","summary":"Seasoned finance leader to drive company's next phase of growth and innovation. ZURICH, Dec. 10, 2025 /PRNewswire/ -- Matrixport Groupis pleased to announce the appointment of Dominik Oggenfuss as Chief Executive Officer of Matrixport Asset Management AG, effective today.\"With our Swiss asset management platform in place, Matrixport Asset Management is entering its next phase focused on scaling an institution-grade business across Europe. Dominik's appointment reflects our priorities in strengthening investment capabilities and building a long-term presence in key European markets.\" said John Ge, CEO of Matrixport Group.\"I am honored to join Matrixport Asset Management AG as CEO and I look forward to working with the talented team. Being part of Matrixport Group, a global digital asset player in Asia, I am convinced we can deliver innovative investment solutions, strengthen client relationships, and expand Matrixport Group's presence in both traditional and digital asset markets in Swi","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2529911/Matrixport_2024_2025_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2529911/Matrixport_2024_2025_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/matrixport-appoints-dominik-oggenfuss-as-chief-executive-officer-of-matrixport-asset-management-ag-302637423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MSB","BK4006","AG","MSB.AU","BK4210","BK7501","BK7067"],"gpt_icon":0},{"id":"2588020600","title":"Mesoblast Participation at Piper Sandler Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2588020600","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588020600?lang=en_us&edition=fundamental","pubTime":"2025-12-04 07:10","pubTimestamp":1764803400,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec.  03, 2025  (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its participation at t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/03/3199432/0/en/Mesoblast-Participation-at-Piper-Sandler-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4150","MSC","MSB","BK4575","BK4006","BK4139","MESO"],"gpt_icon":0},{"id":"2587754974","title":"Mesoblast (ASX:MSB) Is Up 17.3% After Lifting Revenue Guidance and Announcing NIH Trial Collaboration Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2587754974","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587754974?lang=en_us&edition=fundamental","pubTime":"2025-11-29 09:23","pubTimestamp":1764379395,"startTime":"0","endTime":"0","summary":"Mesoblast Limited recently released updated revenue guidance, projecting gross revenue of over US$30.0 million from Ryoncil® sales for the quarter ending December 31, 2025, and announced a collaborative pivotal trial with the NIH-funded Blood and Marrow Transplant Clinical Trials Network for Ryoncil® in adults with severe acute graft versus host disease.\nThis combination of higher sales forecasts and expanded clinical research signals an important step as Mesoblast seeks to broaden both its...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-up-173-after-lifting-revenue-guidance-an","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-up-173-after-lifting-revenue-guidance-an","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB","MSB.AU"],"gpt_icon":0},{"id":"2586248870","title":"A Look at Mesoblast (ASX:MSB) Valuation as New Ryoncil Sales Forecast and Pivotal Trial Spark Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2586248870","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586248870?lang=en_us&edition=fundamental","pubTime":"2025-11-27 13:37","pubTimestamp":1764221823,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) has caught the market's attention with a new revenue forecast for December 2025, expecting sales of Ryoncil to top $30 million, an increase of 37% from the previous quarter. The company also announced a collaboration to launch a pivotal trial that could expand Ryoncil’s use in adults with severe graft versus host disease.\nSee our latest analysis for Mesoblast.\nMesoblast’s upbeat revenue guidance and new clinical trial plans have reinvigorated investor sentiment, reflected...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/a-look-at-mesoblast-asxmsb-valuation-as-new-ryoncil-sales-fo","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/a-look-at-mesoblast-asxmsb-valuation-as-new-ryoncil-sales-fo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB","MSB.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":65,"code":"91000000","status":"200"}]}}